Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies - Wikidata - awgldk - TriplyDB

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

http://www.wikidata.org/entity/Q35128325

about

Linear reduction in thyroid cancer risk by oral contraceptive use: a dose-response meta-analysis of prospective cohort studies Parity and gastric cancer risk: a systematic review and dose-response meta-analysis of prospective cohort studies Statin use and breast cancer survival and risk: a systematic review and meta-analysis Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies Fruits and vegetables intake and risk of bladder cancer: a PRISMA-compliant systematic review and dose-response meta-analysis of prospective cohort studies The utility of web mining for epidemiological research: studying the association between parity and cancer risk.Intercellular adhesion molecule-1 K469E polymorphism and risk of coronary artery disease: a meta-analysis.ABCB1 gene polymorphisms and glucocorticoid-induced avascular necrosis of the femoral head susceptibility: a meta-analysis.Saturated, Monounsaturated and Polyunsaturated Fatty Acids Intake and Risk of Pancreatic Cancer: Evidence from Observational Studies Parity and Cardiovascular Disease Mortality: a Dose-Response Meta-Analysis of Cohort Studies.Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies.Parity and endometrial cancer risk: a meta-analysis of epidemiological studies.Parity and All-cause Mortality in Women and Men: A Dose-Response Meta-Analysis of Cohort Studies.Parity and thyroid cancer risk: a meta-analysis of epidemiological studies The imaging features of metanephric adenoma: a case report and review of literature.Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis.Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies.Association of alpha-ADD1 Gene and Hypertension Risk: A Meta-Analysis.Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).Obesity and Pancreatic Cancer.Physical Activity and Pancreatic Cancer Risk among Urban Chinese: Results from Two Prospective Cohort Studies.Long-term trends in pancreatic cancer mortality in Spain (1952-2012).

P2860

Q27011528-214DBBB7-63D0-4799-9EEA-882D4F3BFFA2 Q28071724-9FDA73EC-A064-4FB2-AFF7-7F8750500F8C Q28082068-191C40FD-0B59-4854-9238-F26E46B9E165 Q28084927-21601C51-E8D0-4DDC-82E1-A9FEAA9CA41C Q28088417-E65D5BF5-590E-4A1F-A156-52E5697CA548 Q30382011-C48E0D2F-3D2B-4D95-B3C0-CB648879C73C Q34742953-1E7BE245-6C9E-4523-8B17-B651C6E03B5C Q34852799-D0312A93-1EE1-4D12-B4F2-C93EAD010DD0 Q35674116-5916FBF1-8AD3-4D0A-95CE-37A9D682261E Q35989519-524A0134-FFB8-4176-944B-9151D1F3FC1F Q36009540-01E5BAA5-BB04-402B-AA43-232933B1E28D Q36274071-5CA99EA5-80E4-4F15-AFBB-BD50C9681D8B Q36499602-D1B0D33D-8FCB-4478-BD2E-50F74F1689C0 Q36797308-67DE4A03-A01B-40F0-83B8-757006C9C431 Q38364684-79824543-A52E-4E4E-9FCF-F61F6A6B4047 Q38536886-E38B0B07-8B50-4B22-9CC1-8E688EED4827 Q38544104-71AB4497-E0BF-446B-90A7-ADCF4D5245A6 Q38999538-BB189B9A-3FAD-4557-B1F9-DD462777C5A2 Q40540489-FCEC0A4F-7602-4C40-821E-30E5B753BB7F Q50856729-EB4760A0-BE61-46E0-BDED-5BCFE6FD38E8 Q51409392-F25B5196-C871-4174-AB72-D9025F651460 Q55399810-4241C8F1-B782-4BEE-986D-1FF10F1F3551

P2860

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

http://www.wikidata.org/entity/Q35128325

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@ast

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@en

type

label

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@ast

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@en

prefLabel

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@ast

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@en

P1433

Q35128325-368706E9-AB36-4299-8A70-24D5480FC9F6

P1476

Q35128325-64E2AD4E-2655-494A-B6C7-760EBF12178F

P2093

Q35128325-711518F2-0495-48A7-A88C-147EC1284133

Q35128325-760E1340-511D-466A-BF0A-C8A8506D08DD

Q35128325-7D3E9B6A-FAAF-4F7D-9B56-34BC23FE0A02

Q35128325-C9071B2D-5D80-4496-BAE0-BEAE4EE0EDF1

Q35128325-DA55CFC4-7AE0-4F9D-81B2-1C679A6A10BB

P2860

Q35128325-09FC001A-02DA-40BB-BBA1-B1DC38EE1857

Q35128325-0BC698A6-DDC4-4EB0-9BA4-ED2A11E5A66D

Q35128325-0C124B62-78A9-429A-995D-E3DC255ED9C2

Q35128325-10CFA5CE-F2EB-4EA9-819E-0325F2F07320

Q35128325-14072308-28D0-4F71-951F-A41CBFE203E9

Q35128325-18B2B706-1A21-4770-A252-6AB6F78E760E

Q35128325-2D228CEC-542F-4C0C-B4AF-80A6FFC09057

Q35128325-3295CCB0-2EA0-4246-9C7C-DE02AD884387

Q35128325-35F59E6E-E388-43A9-99F2-CEF87B16BF18

Q35128325-35F6F658-A349-42A1-AFFB-9A9BECFE1E17

P304

Q35128325-A75FFFB2-404F-4C23-83F1-55696BBA1F51

P31

Q35128325-FBA91938-6509-4451-B7CA-19F1ABB4DA57

Q35128325-a6874c4b-7def-47c0-a499-9ab9f5047520

P356

Q35128325-486A4C43-9685-452A-8372-C696C78C5C0E

P407

Q35128325-06EA58C0-69D7-429C-AEEA-3FCB8F64E4D4

P433

Q35128325-A5134D98-A921-4186-B8EA-2E3B4F45812B

P478

Q35128325-1D69C914-58BF-416E-941A-7E79472DD3D5

P577

Q35128325-22425FA2-207A-4C91-988D-3D466332F762

P5875

Q35128325-33005135-FF08-4981-890D-E30F71539C96

P698

Q35128325-59423A3F-139D-4615-A2D3-E21F70E48649

P932

Q35128325-0DEB1E50-0EB8-4FED-8F5C-93170860C4A9

P356

JOURNAL.PONE.0092738

P1433

P1476

Parity and pancreatic cancer risk: a dose-response meta-analysis of epidemiologic studies

@en

P2093

Hong-Bo Guan

http://www.w3.org/2001/XMLSchema#string

Jingjing Zhu

http://www.w3.org/2001/XMLSchema#string

Lang Wu

http://www.w3.org/2001/XMLSchema#string

Qi-Jun Wu

http://www.w3.org/2001/XMLSchema#string

Tingting Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Parity and kidney cancer risk: evidence from epidemiologic studies

Operating characteristics of a rank correlation test for publication bias

Quantifying heterogeneity in a meta-analysis

Cancer statistics, 2013

Meta-analysis in clinical trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Methods for trend estimation from summarized dose-response data, with applications to meta-analysis

Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality.

Other risk factors for pancreatic cancer: hormonal aspects.

P304

e92738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0092738

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261034331

http://www.w3.org/2001/XMLSchema#string

P698

24658609

http://www.w3.org/2001/XMLSchema#string

P932

3962437

http://www.w3.org/2001/XMLSchema#string